94 related articles for article (PubMed ID: 1348659)
1. Truncated fibronectin. An autologous growth-promoting substance secreted by renal carcinoma cells.
Kochevar GJ; Stanek JA; Rucker EB
Cancer; 1992 May; 69(9):2311-5. PubMed ID: 1348659
[TBL] [Abstract][Full Text] [Related]
2. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.
He Z; Liu S; Guo M; Mao J; Hughson MD
Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424
[TBL] [Abstract][Full Text] [Related]
3. Blockage of autonomous growth of ACHN cells by anti-renal cell carcinoma monoclonal antibody 5F4.
Kochevar J
Cancer Res; 1990 May; 50(10):2968-72. PubMed ID: 2334900
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity and protein expression of APC gene in renal cell carcinomas.
Pećina-Slaus N; Pavelić K; Pavelić J
J Mol Med (Berl); 1999 May; 77(5):446-53. PubMed ID: 10426194
[TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin expression is decreased in metastatic renal cell carcinoma following endostatin gene therapy.
Chaves KC; Turaça LT; Pesquero JB; Mennecier G; Dagli ML; Chammas R; Schor N; Bellini MH
Biomed Pharmacother; 2012 Sep; 66(6):464-8. PubMed ID: 22920414
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin gene expression in proliferating, quiescent, and SV40-infected mouse kidney cells.
Khandjian EW; Salomon C; Léonard N; Tremblay S; Türler H
Exp Cell Res; 1992 Oct; 202(2):464-70. PubMed ID: 1327855
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
[TBL] [Abstract][Full Text] [Related]
9. Novel mitochondrial DNA deletion found in a renal cell carcinoma.
Horton TM; Petros JA; Heddi A; Shoffner J; Kaufman AE; Graham SD; Gramlich T; Wallace DC
Genes Chromosomes Cancer; 1996 Feb; 15(2):95-101. PubMed ID: 8834172
[TBL] [Abstract][Full Text] [Related]
10. Secretion of autocrine growth-promoting activity by renal-carcinoma cells treated with 5-fluorouracil.
Nishimura N; Kanda S; Yogi Y; Kawamura M; Nakamura M; Hyakutake H; Kanetake H; Saito Y
Int J Cancer; 1992 Aug; 52(1):105-9. PubMed ID: 1500215
[TBL] [Abstract][Full Text] [Related]
11. Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene.
Lemm I; Lingott A; Pogge v Strandmann E; Zoidl C; Bulman MP; Hattersley AT; Schulz WA; Ebert T; Ryffel GU
Mol Carcinog; 1999 Apr; 24(4):305-14. PubMed ID: 10326868
[TBL] [Abstract][Full Text] [Related]
12. HIFα independent mechanisms in renal carcinoma cells modulate divergent outcomes in fibronectin assembly mediated by hypoxia and CoCl
Magdaleno C; Dixon L; Rajasekaran N; Varadaraj A
Sci Rep; 2020 Oct; 10(1):18560. PubMed ID: 33122751
[TBL] [Abstract][Full Text] [Related]
13. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
14. Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5.
Sugahara H; Kanakura Y; Furitsu T; Ishihara K; Oritani K; Ikeda H; Kitayama H; Ishikawa J; Hashimoto K; Kanayama Y
J Exp Med; 1994 Jun; 179(6):1757-66. PubMed ID: 7515098
[TBL] [Abstract][Full Text] [Related]
15. The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation.
Cheung CW; Vesey DA; Nicol DL; Johnson DW
Kidney Int; 2004 Apr; 65(4):1272-9. PubMed ID: 15086466
[TBL] [Abstract][Full Text] [Related]
16. A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies.
Berndt A; Köllner R; Richter P; Franz M; Voigt A; Berndt A; Borsi L; Giavazzi R; Neri D; Kosmehl H
Histochem Cell Biol; 2010 Apr; 133(4):467-75. PubMed ID: 20237793
[TBL] [Abstract][Full Text] [Related]
17. Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.
Honchel R; Aksoy IA; Szumlanski C; Wood TC; Otterness DM; Wieben ED; Weinshilboum RM
Mol Pharmacol; 1993 Jun; 43(6):878-87. PubMed ID: 8316220
[TBL] [Abstract][Full Text] [Related]
18. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
[TBL] [Abstract][Full Text] [Related]
19. Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma.
Teratani T; Domoto T; Kuriki K; Kageyama T; Takayama T; Ishikawa A; Ozono S; Nozawa R
Urology; 2007 Feb; 69(2):236-40. PubMed ID: 17320655
[TBL] [Abstract][Full Text] [Related]
20. Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice.
Coltrini D; Ronca R; Belleri M; Zardi L; Indraccolo S; Scarlato V; Giavazzi R; Presta M
J Pathol; 2009 Dec; 219(4):455-62. PubMed ID: 19824060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
